Papillary Thyroid Cancer Review

Papillary thyroid cancer (PTC) is the most common type of thyroid cancer, accounting for around 80% of all thyroid cancer cases. Known for its slow growth and high treatability, PTC originates in the thyroid gland’s hormone-producing cells. Emirates Hospitals offers advanced, patient-focused care for those diagnosed with papillary thyroid cancer, combining state-of-the-art treatments with dedicated support to achieve the best outcomes.

Papillary thyroid cancer develops from the follicular cells of the thyroid, which are responsible for producing thyroid hormones. Often detected as a lump or swelling in the neck, PTC is usually slow-growing and responds well to treatment. While it can spread to lymph nodes, the prognosis remains highly favorable with early intervention. Symptoms may include hoarseness, difficulty swallowing, or a persistent cough.

Causes and Risk Factors for Papillary Thyroid Cancer Review

The exact cause of PTC remains unclear, though several factors may increase the risk. Common risk factors include:

• Radiation Exposure: Individuals exposed to radiation, especially during childhood, have a higher likelihood of developing PTC.
• Family History: Genetic factors may play a role in PTC, particularly if there is a family history of thyroid or other cancers.
• Gender and Age: PTC is more common in women and often occurs in people aged 30 to 50.

Understanding these risk factors helps our specialists at Emirates Hospitals design personalized prevention and treatment strategies.

Comprehensive Diagnostic Approach 

Accurate diagnosis is critical for effective treatment planning. At Emirates Hospitals, we offer a range of diagnostic services, including:

• Ultrasound: This non-invasive imaging tool helps visualize the thyroid gland, identify nodules, and determine if further testing is necessary.
• Fine-Needle Aspiration (FNA) Biopsy: For a definitive diagnosis, an FNA biopsy is performed to collect tissue samples from the thyroid nodule.
• Blood Tests: Though not directly diagnostic for PTC, blood tests help evaluate overall thyroid function and other markers.
• Imaging Studies: Additional imaging such as CT, MRI, or PET scans may be conducted if the cancer has spread to other parts of the body.

Advanced Treatment Options for Papillary Thyroid Cancer Review

At Emirates Hospitals, we provide a range of advanced treatment options tailored to each patient’s needs. Treatment decisions are guided by the cancer’s stage, the patient’s overall health, and their preferences.

• Surgery: Surgery is the primary treatment for PTC, often involving a thyroidectomy (removal of the thyroid gland). In cases where cancer has spread, lymph nodes may also be removed. Our skilled surgeons use the latest techniques to ensure minimal discomfort and optimal recovery.
• Radioactive Iodine Therapy: Papillary thyroid cancer cells absorb iodine, allowing us to target them with radioactive iodine therapy. This therapy is particularly effective in eliminating any remaining cancer cells post-surgery and minimizing recurrence risk.
• Thyroid Hormone Therapy: After thyroidectomy, patients require thyroid hormone replacement therapy to regulate metabolism and prevent the growth of any residual cancer cells. This is a long-term treatment to maintain balanced thyroid function.
• External Radiation Therapy and Chemotherapy: These options are rare for PTC but may be considered for advanced cases or if the cancer does not respond to other treatments. Radiation targets specific areas to control tumor growth, while chemotherapy may be used in cases with extensive metastasis.